(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EYLEA (AFLIBERCEPT) INJECTION 4U

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

EYLEA (AFLIBERCEPT) INJECTION 4U

ST13

US500000085955455

Class

44

Filing

85955455

Registration

4566649

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

07/05/2025

Trademark type

Combined

Nice classes

44

Filing date

06/10/2013

Registration date

07/15/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/11/2024

Last transaction

07/05/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2011-12-00

First use in commerce

2011-12-00

Drawing code

3

Owner type

03

Owner location

Tarrytown, NY

Examiner

MARTIN, EUGENIA

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "EYLEA" in the color blue with the words "(aflibercept) Injection" in the color black directly below the word "EYLEA". Below and to the right of the words "EYLEA" and "(aflibercept) Injection" are two yellow squares side-by-side. The number "4" in the color blue is contained within the left square and the letter "U" in the color blue is contained within the right square.

Holders and representatives

Holders

Regeneron Pharmaceuticals, Inc.

Representatives

Terrence J. McAllister Ruggiero McAllister & McMahon LLC

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionalspatientsconsumersthe general public regarding pharmaceutical products and services

Publications

History of USPTO decisions and trademark events.

52 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/30/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/30/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/30/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/30/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/30/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/11/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/11/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/11/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/11/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

06/27/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/15/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/14/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/14/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/14/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/04/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/04/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/04/2020

E815

TEAS SECTION 8 & 15 RECEIVED

05/16/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/15/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/06/2015

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/06/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

07/15/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/29/2014

PUBO

PUBLISHED FOR OPPOSITION

04/29/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/09/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/26/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/26/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

03/26/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/26/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

03/26/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/26/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/27/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/27/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/27/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/14/2014

GNRT

NON-FINAL ACTION E-MAILED

01/14/2014

CNRT

NON-FINAL ACTION WRITTEN

01/14/2014

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/09/2014

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

12/29/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/19/2013

ALIE

ASSIGNED TO LIE

12/19/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/25/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/23/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/22/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/22/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/28/2013

GNRT

NON-FINAL ACTION E-MAILED

09/28/2013

CNRT

NON-FINAL ACTION WRITTEN

09/28/2013

DOCK

ASSIGNED TO EXAMINER

09/20/2013

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/20/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/19/2013

NWAP

NEW APPLICATION ENTERED

06/13/2013

Continuous trademark protection

Get notified about every new filing that threatens EYLEA (AFLIBERCEPT) INJECTION 4U or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.